Research Breakthrough: Researchers at the University of Texas MD Anderson Cancer Center discovered that blocking a key nutrient while also using immunotherapy could offer a promising new treatment strategy for around half of ovarian clear cell cancers, a disease with limited therapeutic options. Clear cell ovarian cancer is a rare but especially difficult form of … Continued
Medically reviewed by: Sarah Adams, MD, OCRA Scientific Advisor Ovarian cysts are fairly common, but that doesn’t make having them any less nerve-wracking. If you’ve been diagnosed with an ovarian cyst, it’s natural to wonder if that means you have, or are at risk of developing, ovarian cancer. While it’s important to be vigilant when it … Continued
This September, Wrapped in Love has teamed up with multiple Emmy Award-winning talk show host, producer, New York Times Best Selling Author and actress Kelly Ripa to release a Limited-Edition Sock for Ovarian Cancer Awareness Month. At $20 a pair, 100% of every sale will be donated directly to Ovarian Cancer Research Alliance (OCRA) to advance research, advocacy, and support for … Continued
September is Ovarian and Gynecologic Cancer Awareness Month — a time for our community to unite, raise awareness, and push forward in the search for better treatments and cures. As the world’s largest organization dedicated to fighting ovarian and all gynecologic cancers on all fronts, Ovarian Cancer Research Alliance (OCRA) is setting out to raise $300,000 this … Continued
About Gynecologic Cancer Awareness Month September is recognized nationwide as Gynecologic Cancer Awareness Month. This is a dedicated time to raise awareness for all gynecologic cancers, including ovarian, cervical, uterine, vaginal, and vulvar cancers. Throughout the month, OCRA joins forces with patients, caregivers, and supporters to amplify our voices. We focus on educating the public … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance FY 2026 Appropriations & Congressional Recess: A Vital Advocacy Window As Congress continues its August recess, this “district and state work period” transforms into a strategic opportunity. Some lawmakers are focused on local engagement like town halls and community meetings, which make it the … Continued
The Rio Grande Valley community will once again come together to ride for research as OCRA’s Ovarian Cycle Rio Grande Valley returns on September 13th at TRYBE Cycle. This year’s event is especially meaningful, marking the 10th anniversary of the fundraiser. Registration is open now. Event chair and ovarian cancer survivor Marlynn Olivarez recently appeared on KRGV-TV Channel 5 News with Dina Herrera Garza, … Continued
Scientists have identified sixteen potential therapeutic targets in low-grade serous ovarian cancer by studying proteins at the molecular level, with results published on August 11, 2025, in the journal Cancer Cell. The research was led by Ernst Lengyel, MD, PhD of University of Chicago, along with Matthias Mann, PhD, of the Max Planck Institute of … Continued
Research Breakthrough: Researchers at the University of Texas MD Anderson Cancer Center identified key gene changes in certain mucinous ovarian cancers with potential to guide care and predict outcomes when identified through genetic testing at diagnosis. Mucinous ovarian cancer is a rare type of ovarian cancer that behaves differently from more common forms, and doctors … Continued
On April 1, 2025, the Rivkin Center for Ovarian Cancer Research officially joined forces with OCRA to expand education, support and research for the ovarian and gynecologic cancer community. Together, we are carrying forward the Rivkin mission to find a cure, honoring stories like Mary’s and working to ensure others have the chance for earlier … Continued
Research Breakthrough: At The University of Chicago, researchers systematically tested existing therapies to find an effective drug combination that shows promise as a treatment for ovarian cancer. Scientists are looking for better ways to treat high-grade serous ovarian cancer, especially the cancer cells that survive standard chemotherapy (carboplatin) and lead to recurrence. In this study, researchers … Continued
OCRA Rivkin Family SummeRun Raises Over $320,000 for Research More than 900 participants gathered at Seattle’s Seward Park for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, raising more than $320,000 to advance innovative ovarian cancer research. Now in its 32nd year, the beloved 5K run/walk brought together survivors, families, friends, and supporters—all united in … Continued
Get email updates about research news, action alerts, and ways to join the fight.
A global, Al-powered ecosystem designed to transform gynecologic cancer research—connecting patients, researchers, and clinicians to accelerate breakthroughs.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
